CCM
AGN

Cantillon Capital Management’s Allergan plc AGN Stock Holding History

Cantillon Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-204,467
Closed -$34.1M – 35
2018
Q2 		$34.1M Sell
204,467
-806,289
-80% -$129M 0.37% 34
2018
Q1 		$170M Sell
1,010,756
-19,501
-2% -$3.27M 1.93% 25
2017
Q4 		$169M Sell
1,030,257
-72,720
-7% -$13M 2% 22
2017
Q3 		$226M Buy
1,102,977
+100,526
+10% +$23.4M 2.63% 20
2017
Q2 		$244M Sell
1,002,451
-42,000
-4% -$9.87M 3.04% 18
2017
Q1 		$250M Buy
1,044,451
+90,331
+9% +$21M 3.19% 18
2016
Q4 		$200M Sell
954,120
-32,430
-3% -$6.72M 2.81% 20
2016
Q3 		$227M Buy
986,550
+250,540
+34% +$61.2M 3.21% 16
2016
Q2 		$170M Buy
+736,010
New +$170M 2.86% 17

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Cantillon Capital Management's AGN Position: Q3 2018 in Review

Cantillon Capital Management sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 204,467 shares — an estimated $34.1M sold.

Cantillon Capital Management first reported a position in AGN in Q2 2016 and held it in 9 quarters. The position peaked at $250M in Q1 2017. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • Cantillon Capital Management reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
  • Cantillon Capital Management sold 204,467 Allergan plc shares in Q3 2018, an estimated $34.1M.
  • Cantillon Capital Management first reported a position in Allergan plc in Q2 2016 and held it in 9 quarters.
  • Cantillon Capital Management's Allergan plc position peaked at $250M in Q1 2017.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Cantillon Capital Management's 13F filing for Q3 2018, filed 9 Nov 2018.